IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $96,336,933 | -23.0% | 2,448,829 | -52.4% | 15.80% | -35.2% |
| Q1 2023 | $125,083,401 | +13.6% | 5,141,118 | 0.0% | 24.38% | +25.5% |
| Q4 2022 | $110,071,336 | +58.2% | 5,141,118 | +32.6% | 19.43% | -6.9% |
| Q3 2022 | $69,570,000 | +148.2% | 3,877,903 | +33.1% | 20.87% | +75.2% |
| Q2 2022 | $28,035,000 | -33.8% | 2,914,250 | +15.8% | 11.91% | -30.0% |
| Q1 2022 | $42,360,000 | +45.5% | 2,516,920 | +44.5% | 17.00% | +24.7% |
| Q4 2021 | $29,113,000 | – | 1,741,228 | – | 13.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |